Alison Beech

Anna Nolan is counsel in the Financial Restructuring & Reorganization Practice in Alston & Bird’s London office. With over 10 years of experience, Anna assists a wide range of clients including hedge funds, special situations investors, trustees, providers of rescue and exit finance, issuers, sponsors, bondholder committees, administrators, and debtors with distressed transactions, conducting corporate, and financial restructurings and general insolvency matters.

Mark Sperotto is a partner in the London office of Gibson, Dunn and Crutcher and a member of the Corporate Transactional practice group. Mr. Sperotto has broad experience in both the UK and Italian markets, covering all aspects of corporate, private equity and investment banking with a focus on cross-border M&A, leveraged buy-outs, fund establishment and international corporate finance and equity capital markets transactions. Mr. Sperotto’s experience extends to advising private equ...

David Evans is Chair of Goodwin’s European offices and a partner in Goodwin’s Real Estate Industry group. He is a former member of the firm’s Executive Committee. Mr. Evans' practice focuses on all aspects of real estate fund structuring and formation, as well as joint ventures and mergers and acquisitions in the real estate arena. Mr. Evans has considerable experience dealing with complex tax and real estate issues applicable to fund structuring, for both UK and pan-Europea...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Gary Born is the chair of the International Arbitration Practice Group. Mr. Born is widely regarded as the world's preeminent authority on international commercial arbitration and international litigation. He has been ranked for more than 20 years as one of the world's leading international arbitration advocates and the leading arbitration practitioner in London.

Anthony Maton has more than 25 years' experience of litigating claims in the UK, Europe and across the globe. In 2009, Anthony co-founded Hausfeld & Co LLP in London which he led as Managing Partner until 2021. He was appointed Global Co-Chair in January 2022.

Clients value the support, guidance, and leadership that Phillip Taylor brings to a situation and his technical and commercial approach to delivering innovative solutions to the most complex issues involving international restructuring, special situations, and insolvency. He represents companies, creditors, and investors in all parts of the capital structure, as well as corporate trustees, agents, directors, and insolvency practitioners. Phillip routinely handles both contentious and non-cont...

Hamid Yunis advises clients on complex areas of transactional law (M&A, Investments, Private Equity, Major Projects and Corporate Finance) predominantly within the health industry and on infrastructure transactions. He has substantial global experience in innovative structures for complex joint ventures, public-private partnerships and funding arrangements. Hamid’s global client base includes health care providers, medical products manufacturers and organizations establishing &ldquo...

Steven Davis is a partner in the Corporate Department, co-head of our global Private Equity and M&A Group and co-head of the London office.Steven’s practice focuses on buyouts, buy-ins, and strategic mergers & acquisitions. He has considerable industry knowledge in the consumer, retail, financial, business services, sports and healthcare sectors, and has advised a broad range of clients, including private equity sponsors, management teams, financial institutions and public and p...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...